IL95021A - History of Acid-7-Carboxy-Pyrolo] B-2,1 [Thiazole-3-thiazole-3-acetic acid, preparation and pharmaceutical preparations containing them - Google Patents
History of Acid-7-Carboxy-Pyrolo] B-2,1 [Thiazole-3-thiazole-3-acetic acid, preparation and pharmaceutical preparations containing themInfo
- Publication number
- IL95021A IL95021A IL9502190A IL9502190A IL95021A IL 95021 A IL95021 A IL 95021A IL 9502190 A IL9502190 A IL 9502190A IL 9502190 A IL9502190 A IL 9502190A IL 95021 A IL95021 A IL 95021A
- Authority
- IL
- Israel
- Prior art keywords
- group
- methyl
- thiazol
- compound
- ylidene
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title description 2
- 238000002360 preparation method Methods 0.000 title description 2
- PYFLSQLGVOGVRX-UHFFFAOYSA-N 3-(carboxymethyl)pyrrolo[2,1-b][1,3]thiazole-7-carboxylic acid Chemical class C(=O)(O)C=1C=CN2C=1SC=C2CC(=O)O PYFLSQLGVOGVRX-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 110
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 35
- 125000001424 substituent group Chemical group 0.000 claims abstract description 32
- 150000003839 salts Chemical class 0.000 claims abstract description 28
- 125000003277 amino group Chemical group 0.000 claims abstract description 21
- 125000003118 aryl group Chemical group 0.000 claims abstract description 21
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 20
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 15
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 13
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 12
- 125000004122 cyclic group Chemical group 0.000 claims abstract description 11
- 125000005842 heteroatom Chemical group 0.000 claims abstract description 10
- 125000004430 oxygen atom Chemical group O* 0.000 claims abstract description 10
- 125000006413 ring segment Chemical group 0.000 claims abstract description 10
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 10
- 125000004434 sulfur atom Chemical group 0.000 claims abstract description 10
- 125000005110 aryl thio group Chemical group 0.000 claims abstract description 8
- 125000004104 aryloxy group Chemical group 0.000 claims abstract description 7
- 125000005843 halogen group Chemical group 0.000 claims description 10
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 150000007524 organic acids Chemical class 0.000 claims description 5
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 claims description 4
- 150000008065 acid anhydrides Chemical class 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 3
- 101150047265 COR2 gene Proteins 0.000 claims description 2
- 101100467189 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) QCR2 gene Proteins 0.000 claims description 2
- 150000008064 anhydrides Chemical class 0.000 claims 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- 208000019423 liver disease Diseases 0.000 abstract description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 8
- 125000001072 heteroaryl group Chemical group 0.000 abstract description 7
- 239000000825 pharmaceutical preparation Substances 0.000 abstract description 7
- 125000006165 cyclic alkyl group Chemical group 0.000 abstract description 6
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 125000003282 alkyl amino group Chemical group 0.000 abstract description 4
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 90
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 67
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 64
- 101150041968 CDC13 gene Proteins 0.000 description 63
- -1 1 , 1-dimethyl-butyl Chemical group 0.000 description 53
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 51
- 238000000921 elemental analysis Methods 0.000 description 44
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- 239000000203 mixture Substances 0.000 description 25
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 22
- 239000007864 aqueous solution Substances 0.000 description 22
- 239000002904 solvent Substances 0.000 description 22
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 21
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 238000001228 spectrum Methods 0.000 description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 13
- 229920006395 saturated elastomer Polymers 0.000 description 13
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000003960 organic solvent Substances 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 238000010898 silica gel chromatography Methods 0.000 description 7
- KDISMIMTGUMORD-UHFFFAOYSA-N N-acetylpiperidine Natural products CC(=O)N1CCCCC1 KDISMIMTGUMORD-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 6
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 208000006454 hepatitis Diseases 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- DMZCCKBUYQTDDB-UHFFFAOYSA-N propan-2-yl 4-methyl-2-sulfanylidenepyrrolidine-3-carboxylate Chemical compound CC(C)OC(=O)C1C(C)CNC1=S DMZCCKBUYQTDDB-UHFFFAOYSA-N 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- KYWXRBNOYGGPIZ-UHFFFAOYSA-N 1-morpholin-4-ylethanone Chemical compound CC(=O)N1CCOCC1 KYWXRBNOYGGPIZ-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 231100000753 hepatic injury Toxicity 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- DUYAAUVXQSMXQP-UHFFFAOYSA-M thioacetate Chemical compound CC([S-])=O DUYAAUVXQSMXQP-UHFFFAOYSA-M 0.000 description 4
- VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical compound CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 description 4
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 3
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 3
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
- 125000004663 dialkyl amino group Chemical group 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- IZNVSBHWZFZPIC-UHFFFAOYSA-N ethyl 4-methyl-2-sulfanylidenepyrrolidine-3-carboxylate Chemical compound CCOC(=O)C1C(C)CNC1=S IZNVSBHWZFZPIC-UHFFFAOYSA-N 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 210000003494 hepatocyte Anatomy 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- YDORIQRKHGPPSQ-UHFFFAOYSA-N propan-2-yl 6-methyl-3-[2-(methylamino)-2-oxoethylidene]-5,6-dihydropyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound CC1CN2C(=CC(=O)NC)CSC2=C1C(=O)OC(C)C YDORIQRKHGPPSQ-UHFFFAOYSA-N 0.000 description 3
- 239000011877 solvent mixture Substances 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- LSKMHOJTZLJJQW-UHFFFAOYSA-N 1-thiomorpholin-4-ylethanone Chemical compound CC(=O)N1CCSCC1 LSKMHOJTZLJJQW-UHFFFAOYSA-N 0.000 description 2
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- XZXLYGAUEAPJET-UHFFFAOYSA-N 5-amino-3h-1-benzofuran-2-one Chemical compound NC1=CC=C2OC(=O)CC2=C1 XZXLYGAUEAPJET-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- NWZKEMYSVMQDMJ-UHFFFAOYSA-N N12CC(C)C(C(=O)OC(C)C)=C2SCC1=C1CSCCN1C(C)=O Chemical compound N12CC(C)C(C(=O)OC(C)C)=C2SCC1=C1CSCCN1C(C)=O NWZKEMYSVMQDMJ-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000009435 amidation Effects 0.000 description 2
- 238000007112 amidation reaction Methods 0.000 description 2
- 229940047583 cetamide Drugs 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 2
- KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical compound CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 229940017219 methyl propionate Drugs 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 2
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- NXPWHCMMTCKBJA-UHFFFAOYSA-N propan-2-yl 3-(2-amino-2-oxoethyl)-6-methyl-2,3-dihydropyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound NC(=O)CC1CSC2=C(C(=O)OC(C)C)C(C)=CN21 NXPWHCMMTCKBJA-UHFFFAOYSA-N 0.000 description 2
- CJBJEYVMWUKHSF-UHFFFAOYSA-N propan-2-yl 3-(2-amino-2-oxoethylidene)-6-methylpyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound NC(=O)C=C1CSC2=C(C(=O)OC(C)C)C(C)=CN21 CJBJEYVMWUKHSF-UHFFFAOYSA-N 0.000 description 2
- RHRFBDQDHVAAEC-UHFFFAOYSA-N propan-2-yl 3-(2-ethoxy-2-oxoethyl)-6-methyl-5,6-dihydropyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound CC1CN2C(CC(=O)OCC)=CSC2=C1C(=O)OC(C)C RHRFBDQDHVAAEC-UHFFFAOYSA-N 0.000 description 2
- HLXGPRSVIXIUGF-UHFFFAOYSA-N propan-2-yl 3-(2-oxo-2-phenylsulfanylethylidene)-5,6-dihydropyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound N12CCC(C(=O)OC(C)C)=C2SCC1=CC(=O)SC1=CC=CC=C1 HLXGPRSVIXIUGF-UHFFFAOYSA-N 0.000 description 2
- BDHKXARAPJBCBD-UHFFFAOYSA-N propan-2-yl 3-[2-(methylamino)-2-oxoethylidene]pyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound C1=CN2C(=CC(=O)NC)CSC2=C1C(=O)OC(C)C BDHKXARAPJBCBD-UHFFFAOYSA-N 0.000 description 2
- XYOPEXCAQRGUIQ-UHFFFAOYSA-N propan-2-yl 6-methyl-3-(2-morpholin-4-yl-2-oxoethyl)-2,3-dihydropyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound C1SC2=C(C(=O)OC(C)C)C(C)=CN2C1CC(=O)N1CCOCC1 XYOPEXCAQRGUIQ-UHFFFAOYSA-N 0.000 description 2
- YPJOJHBRMCSWKL-UHFFFAOYSA-N propan-2-yl 6-methyl-3-[2-(methylamino)-2-oxoethylidene]pyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound CC1=CN2C(=CC(=O)NC)CSC2=C1C(=O)OC(C)C YPJOJHBRMCSWKL-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- KZJPVUDYAMEDRM-UHFFFAOYSA-M silver;2,2,2-trifluoroacetate Chemical compound [Ag+].[O-]C(=O)C(F)(F)F KZJPVUDYAMEDRM-UHFFFAOYSA-M 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- ZNAQDZMDCOIOGT-UHFFFAOYSA-N (4-nitrophenyl) 4-bromo-3-oxobutanoate Chemical compound [O-][N+](=O)C1=CC=C(OC(=O)CC(=O)CBr)C=C1 ZNAQDZMDCOIOGT-UHFFFAOYSA-N 0.000 description 1
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- 125000005918 1,2-dimethylbutyl group Chemical group 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- JZXDQNOIVDPSKJ-UHFFFAOYSA-N 2-(6-methyl-7-propan-2-yloxycarbonyl-2,3-dihydropyrrolo[2,1-b][1,3]thiazol-3-yl)acetic acid Chemical compound OC(=O)CC1CSC2=C(C(=O)OC(C)C)C(C)=CN21 JZXDQNOIVDPSKJ-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- GBJCWBWQIQXFLH-UHFFFAOYSA-N 2h-pyrrolo[2,3-d][1,3]thiazole Chemical class C1=NC2=NCSC2=C1 GBJCWBWQIQXFLH-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- JRLTTZUODKEYDH-UHFFFAOYSA-N 8-methylquinoline Chemical group C1=CN=C2C(C)=CC=CC2=C1 JRLTTZUODKEYDH-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 101100236975 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GAL11 gene Proteins 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- ATPFRGQBOVFFQM-WJIDAKASSA-N [(1s,3r,7r,8r,8as)-3-(hydroxymethyl)-8-[2-[(2r,4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate Chemical compound C([C@@H]1[C@H](C)C=CC2=C[C@H](CO)C[C@@H]([C@@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 ATPFRGQBOVFFQM-WJIDAKASSA-N 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- BQNZTLDPEPZVKX-UHFFFAOYSA-N butan-2-yl 2-sulfanylidenepyrrolidine-3-carboxylate Chemical compound CCC(C)OC(=O)C1CCNC1=S BQNZTLDPEPZVKX-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- QJQMJMCWZCBYMU-UHFFFAOYSA-N cyclohexyl 6-methyl-3-[2-(methylamino)-2-oxoethylidene]pyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound CC1=CN2C(=CC(=O)NC)CSC2=C1C(=O)OC1CCCCC1 QJQMJMCWZCBYMU-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000311 effect on hepatitis Effects 0.000 description 1
- MGDWUTQKXCZNAJ-UHFFFAOYSA-N ethyl 4-bromo-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)CBr MGDWUTQKXCZNAJ-UHFFFAOYSA-N 0.000 description 1
- RUVIJIQXIMNWAC-UHFFFAOYSA-N ethyl 4-methyl-2-oxopyrrolidine-3-carboxylate Chemical compound CCOC(=O)C1C(C)CNC1=O RUVIJIQXIMNWAC-UHFFFAOYSA-N 0.000 description 1
- RSDQIMOBRSKOBO-UHFFFAOYSA-N ethyl 4-phenyl-2-sulfanylidenepyrrolidine-3-carboxylate Chemical compound C1NC(=S)C(C(=O)OCC)C1C1=CC=CC=C1 RSDQIMOBRSKOBO-UHFFFAOYSA-N 0.000 description 1
- MZTPMROECWQDES-UHFFFAOYSA-N ethyl 4-propan-2-yl-2-sulfanylidenepyrrolidine-3-carboxylate Chemical compound CCOC(=O)C1C(C(C)C)CNC1=S MZTPMROECWQDES-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- RWIKCBHOVNDESJ-NSCUHMNNSA-N methyl (e)-4-bromobut-2-enoate Chemical compound COC(=O)\C=C\CBr RWIKCBHOVNDESJ-NSCUHMNNSA-N 0.000 description 1
- SMWPLZYNUWNGEM-UHFFFAOYSA-N methyl 3-(2-ethoxy-2-oxoethylidene)-5,6-dihydropyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound COC(=O)C=1CCN2C1SCC2=CC(=O)OCC SMWPLZYNUWNGEM-UHFFFAOYSA-N 0.000 description 1
- UYYUQABAVDLYCO-UHFFFAOYSA-N methyl 4-methyl-2-sulfanylidenepyrrolidine-3-carboxylate Chemical compound COC(=O)C1C(C)CNC1=S UYYUQABAVDLYCO-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002004 n-butylamino group Chemical group [H]N(*)C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- TZFYUHQCRHEAKL-UHFFFAOYSA-N propan-2-yl 3-(2-ethoxy-2-oxoethylidene)-5,6-dihydropyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound C1CN2C(=CC(=O)OCC)CSC2=C1C(=O)OC(C)C TZFYUHQCRHEAKL-UHFFFAOYSA-N 0.000 description 1
- YNQQYZYEEONHCD-UHFFFAOYSA-N propan-2-yl 3-(2-methoxy-2-oxoethyl)-6-methyl-2,3,5,6-tetrahydropyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound CC1CN2C(CC(=O)OC)CSC2=C1C(=O)OC(C)C YNQQYZYEEONHCD-UHFFFAOYSA-N 0.000 description 1
- DHZJGRJJWBLIBP-UHFFFAOYSA-N propan-2-yl 3-(2-methoxy-2-oxoethyl)-6-methyl-2,3-dihydropyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound CC1=CN2C(CC(=O)OC)CSC2=C1C(=O)OC(C)C DHZJGRJJWBLIBP-UHFFFAOYSA-N 0.000 description 1
- BFGHPMOBQLHUNF-UHFFFAOYSA-N propan-2-yl 3-(4-acetylmorpholin-3-ylidene)-6-methylpyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound C1SC2=C(C(=O)OC(C)C)C(C)=CN2C1=C1COCCN1C(C)=O BFGHPMOBQLHUNF-UHFFFAOYSA-N 0.000 description 1
- BJBNOGVLOYAKBK-UHFFFAOYSA-N propan-2-yl 3-(4-acetylthiomorpholin-3-ylidene)-6-methylpyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound C1SC2=C(C(=O)OC(C)C)C(C)=CN2C1=C1CSCCN1C(C)=O BJBNOGVLOYAKBK-UHFFFAOYSA-N 0.000 description 1
- FLPZMBHNDAVOTC-UHFFFAOYSA-N propan-2-yl 3-[2-(dimethylamino)-2-oxoethylidene]-5,6-dihydropyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound S1CC(=CC(=O)N(C)C)N2CCC(C(=O)OC(C)C)=C21 FLPZMBHNDAVOTC-UHFFFAOYSA-N 0.000 description 1
- VUMZXCYTDXAYMU-UHFFFAOYSA-N propan-2-yl 3-[2-(dimethylamino)-2-oxoethylidene]-6-methyl-5,6-dihydropyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound S1CC(=CC(=O)N(C)C)N2CC(C)C(C(=O)OC(C)C)=C21 VUMZXCYTDXAYMU-UHFFFAOYSA-N 0.000 description 1
- MPRFPBZQDMJWMT-UHFFFAOYSA-N propan-2-yl 3-[2-(ethylamino)-2-oxoethylidene]-6-methylpyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound CC1=CN2C(=CC(=O)NCC)CSC2=C1C(=O)OC(C)C MPRFPBZQDMJWMT-UHFFFAOYSA-N 0.000 description 1
- CZQAGJGQQCOQQC-UHFFFAOYSA-N propan-2-yl 3-[2-(methylamino)-2-oxoethylidene]-5,6-dihydropyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound C1CN2C(=CC(=O)NC)CSC2=C1C(=O)OC(C)C CZQAGJGQQCOQQC-UHFFFAOYSA-N 0.000 description 1
- HUHVROUZEHXDRR-UHFFFAOYSA-N propan-2-yl 3-[2-(methylamino)-2-oxoethylidene]-6-propan-2-ylpyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound CC(C)C1=CN2C(=CC(=O)NC)CSC2=C1C(=O)OC(C)C HUHVROUZEHXDRR-UHFFFAOYSA-N 0.000 description 1
- XCDKZWNJNUWQKN-UHFFFAOYSA-N propan-2-yl 4-phenyl-2-sulfanylidenepyrrolidine-3-carboxylate Chemical compound C1NC(=S)C(C(=O)OC(C)C)C1C1=CC=CC=C1 XCDKZWNJNUWQKN-UHFFFAOYSA-N 0.000 description 1
- OPYQYJHXOUZFOD-UHFFFAOYSA-N propan-2-yl 4-propan-2-yl-2-sulfanylidenepyrrolidine-3-carboxylate Chemical compound CC(C)OC(=O)C1C(C(C)C)CNC1=S OPYQYJHXOUZFOD-UHFFFAOYSA-N 0.000 description 1
- ZLLFSZAAQULWQZ-UHFFFAOYSA-N propan-2-yl 6-methyl-3-(2-morpholin-4-yl-2-oxoethylidene)pyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound C1SC2=C(C(=O)OC(C)C)C(C)=CN2C1=CC(=O)N1CCOCC1 ZLLFSZAAQULWQZ-UHFFFAOYSA-N 0.000 description 1
- WBTMFEHBBQNCQI-UHFFFAOYSA-N propan-2-yl 6-methyl-3-(2-oxo-2-piperidin-1-ylethylidene)pyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound C1SC2=C(C(=O)OC(C)C)C(C)=CN2C1=CC(=O)N1CCCCC1 WBTMFEHBBQNCQI-UHFFFAOYSA-N 0.000 description 1
- CRIBEDWRRDVCIQ-UHFFFAOYSA-N propan-2-yl 6-methyl-3-[2-(4-nitrophenoxy)-2-oxoethylidene]-5,6-dihydropyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound N12CC(C)C(C(=O)OC(C)C)=C2SCC1=CC(=O)OC1=CC=C([N+]([O-])=O)C=C1 CRIBEDWRRDVCIQ-UHFFFAOYSA-N 0.000 description 1
- MLZPNFWPSVWFIY-UHFFFAOYSA-N propan-2-yl 6-methyl-3-[2-(methylamino)-2-oxoethyl]-2,3,5,6-tetrahydropyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound CC1CN2C(CC(=O)NC)CSC2=C1C(=O)OC(C)C MLZPNFWPSVWFIY-UHFFFAOYSA-N 0.000 description 1
- IIXQPUHNANAGGD-UHFFFAOYSA-N propan-2-yl 6-methyl-3-[2-(methylamino)-2-oxoethyl]-2,3-dihydropyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound CC1=CN2C(CC(=O)NC)CSC2=C1C(=O)OC(C)C IIXQPUHNANAGGD-UHFFFAOYSA-N 0.000 description 1
- ADHZUOFVPMTCEL-UHFFFAOYSA-N propan-2-yl 6-methyl-3-[2-(methylamino)-2-oxoethyl]-5,6-dihydropyrrolo[2,1-b][1,3]thiazole-7-carboxylate Chemical compound CC1CN2C(CC(=O)NC)=CSC2=C1C(=O)OC(C)C ADHZUOFVPMTCEL-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- DZYILUKBCXGPEX-UHFFFAOYSA-N tert-butyl 2-oxopyrrolidine-3-carboxylate Chemical compound CC(C)(C)OC(=O)C1CCNC1=O DZYILUKBCXGPEX-UHFFFAOYSA-N 0.000 description 1
- DNKFYUMCAJNUDX-UHFFFAOYSA-N tert-butyl 2-sulfanylidenepyrrolidine-3-carboxylate Chemical compound CC(C)(C)OC(=O)C1CCNC1=S DNKFYUMCAJNUDX-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Detergent Compositions (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15114189 | 1989-06-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL95021A0 IL95021A0 (en) | 1991-06-10 |
| IL95021A true IL95021A (en) | 1994-06-24 |
Family
ID=15512262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL9502190A IL95021A (en) | 1989-06-13 | 1990-07-10 | History of Acid-7-Carboxy-Pyrolo] B-2,1 [Thiazole-3-thiazole-3-acetic acid, preparation and pharmaceutical preparations containing them |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5098919A (no) |
| EP (1) | EP0410224B1 (no) |
| JP (1) | JP2875605B2 (no) |
| KR (1) | KR910002874A (no) |
| CN (1) | CN1025337C (no) |
| AT (1) | ATE132870T1 (no) |
| AU (1) | AU624724B2 (no) |
| CA (1) | CA2021135A1 (no) |
| DD (1) | DD296492A5 (no) |
| DE (1) | DE69024713T2 (no) |
| DK (1) | DK0410224T3 (no) |
| ES (1) | ES2084622T3 (no) |
| FI (1) | FI903511A0 (no) |
| GR (1) | GR3018798T3 (no) |
| HU (1) | HU207331B (no) |
| IE (1) | IE902545A1 (no) |
| IL (1) | IL95021A (no) |
| NO (1) | NO903084L (no) |
| NZ (1) | NZ234450A (no) |
| PT (1) | PT94688A (no) |
| RU (2) | RU1836374C (no) |
| YU (1) | YU136490A (no) |
| ZA (1) | ZA905407B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050244892A1 (en) * | 2004-02-27 | 2005-11-03 | Lazar Mitchell A | Resistin as a marker and therapeutic target for cardiovascular disease |
| JP5415520B2 (ja) * | 2008-04-09 | 2014-02-12 | ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 最大酸素消費量低下の予測のためのプロ−エンドセリン−１ |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4193926A (en) * | 1974-03-20 | 1980-03-18 | Schering Aktiengesellschaft | 4-(Polyalkoxy phenyl)-2-pyrrolidones |
| US4347186A (en) * | 1980-10-20 | 1982-08-31 | Syntex (U.S.A.) Inc. | Process for preparing 5-aroyl 1,2-dihydro-3-H pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein |
-
1990
- 1990-07-10 IL IL9502190A patent/IL95021A/en not_active IP Right Cessation
- 1990-07-10 DD DD90342652A patent/DD296492A5/de not_active IP Right Cessation
- 1990-07-10 ZA ZA905407A patent/ZA905407B/xx unknown
- 1990-07-11 KR KR1019900010442A patent/KR910002874A/ko not_active Application Discontinuation
- 1990-07-11 AU AU58904/90A patent/AU624724B2/en not_active Ceased
- 1990-07-11 NZ NZ234450A patent/NZ234450A/xx unknown
- 1990-07-11 FI FI903511A patent/FI903511A0/fi not_active Application Discontinuation
- 1990-07-11 NO NO90903084A patent/NO903084L/no unknown
- 1990-07-12 EP EP90113378A patent/EP0410224B1/en not_active Expired - Lifetime
- 1990-07-12 ES ES90113378T patent/ES2084622T3/es not_active Expired - Lifetime
- 1990-07-12 PT PT94688A patent/PT94688A/pt not_active Application Discontinuation
- 1990-07-12 AT AT90113378T patent/ATE132870T1/de not_active IP Right Cessation
- 1990-07-12 RU SU904830592A patent/RU1836374C/ru active
- 1990-07-12 DE DE69024713T patent/DE69024713T2/de not_active Expired - Fee Related
- 1990-07-12 DK DK90113378.5T patent/DK0410224T3/da active
- 1990-07-12 YU YU136490A patent/YU136490A/sh unknown
- 1990-07-12 IE IE254590A patent/IE902545A1/en unknown
- 1990-07-13 CN CN90107066A patent/CN1025337C/zh not_active Expired - Fee Related
- 1990-07-13 HU HU904214A patent/HU207331B/hu not_active IP Right Cessation
- 1990-07-13 JP JP2186896A patent/JP2875605B2/ja not_active Expired - Fee Related
- 1990-07-13 US US07/552,031 patent/US5098919A/en not_active Expired - Fee Related
- 1990-07-13 CA CA002021135A patent/CA2021135A1/en not_active Abandoned
-
1991
- 1991-08-22 RU SU915001347A patent/RU2026288C1/ru active
-
1996
- 1996-01-25 GR GR960400186T patent/GR3018798T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE132870T1 (de) | 1996-01-15 |
| AU5890490A (en) | 1991-01-17 |
| PT94688A (pt) | 1991-03-20 |
| EP0410224A1 (en) | 1991-01-30 |
| EP0410224B1 (en) | 1996-01-10 |
| HUT57221A (en) | 1991-11-28 |
| AU624724B2 (en) | 1992-06-18 |
| DD296492A5 (de) | 1991-12-05 |
| ES2084622T3 (es) | 1996-05-16 |
| DK0410224T3 (da) | 1996-02-05 |
| ZA905407B (en) | 1991-04-24 |
| RU2026288C1 (ru) | 1995-01-09 |
| CN1049350A (zh) | 1991-02-20 |
| GR3018798T3 (en) | 1996-04-30 |
| NO903084D0 (no) | 1990-07-11 |
| DE69024713D1 (de) | 1996-02-22 |
| NZ234450A (en) | 1991-10-25 |
| CA2021135A1 (en) | 1991-01-14 |
| JPH03128385A (ja) | 1991-05-31 |
| CN1025337C (zh) | 1994-07-06 |
| JP2875605B2 (ja) | 1999-03-31 |
| IE902545A1 (en) | 1991-02-27 |
| RU1836374C (ru) | 1993-08-23 |
| HU904214D0 (en) | 1990-12-28 |
| HU207331B (en) | 1993-03-29 |
| US5098919A (en) | 1992-03-24 |
| KR910002874A (ko) | 1991-02-26 |
| DE69024713T2 (de) | 1996-06-13 |
| IL95021A0 (en) | 1991-06-10 |
| NO903084L (no) | 1991-01-14 |
| YU136490A (sh) | 1992-09-07 |
| FI903511A0 (fi) | 1990-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0054951B1 (en) | Dibenz(b,f)(1,4)oxazepine derivatives, process for preparing the same, and pharmaceutical compositions comprising the same | |
| KR930005002B1 (ko) | 피리돈카복실산 유도체의 제조방법 | |
| RU2129546C1 (ru) | 6,9-бис(аминозамещенные)-бензо(g)изохинолин-5,10-дионы, способ их получения, фармацевтическая композиция на их основе и способ ингибирования опухолей у млекопитающих | |
| CA2048511A1 (en) | Tricyclic compound or salts thereof, method for producing the same and antimicrobial agent containing the same | |
| FI76809B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara nya 5-(3-pyridyl)pyrrolo/1,2-c/tiazol-7- karboxamid-derivat. | |
| CA1038386A (en) | Pyrrolo(3,4-d) pyrimidines and methods for their preparation | |
| SU1395143A3 (ru) | Способ получени производных 1,6-нафтиридина в виде рацематов или энантиомеров,или их кислотно-аддитивных солей | |
| EP0410224B1 (en) | Pyrrolo [2,1-b]thiazole derivatives | |
| US3888983A (en) | Derivatives of thiazolino-pyrimidin-6-ones, in inducing analgesia | |
| AU604726B2 (en) | Antiarrhythmic agent | |
| AU699636B2 (en) | Bicyclic amino group-substituted pyridonecarboxylic acid derivatives, esters thereof and salts thereof, and bicyclic amines useful as intermediates thereof | |
| US3073826A (en) | 3-pyrrolidylmethyl-4-quinazolones | |
| CA2035397C (en) | Hexahydropyrrolo¬2,3-b|indole carbamates, -ureas, -amides and related compounds, a process for their preparation and their use as medicaments | |
| US4701466A (en) | Dibenz[be]oxepin-acetic acid derivatives, the preparation thereof and their application in therapy | |
| US4228168A (en) | Azepino [1,2,3-lm]-β-carboline compounds and pharmaceutical composition thereof | |
| US5236926A (en) | 9-substituted-8-halo or -8-hydroxy-9-deazaguanines as inhibitors or PNP for pharmaceutical compositions | |
| GB2030133A (en) | Tetrahydrothiopyrano (2,3-b) indole derivatives | |
| SU1181546A3 (ru) | Способ получени конденсированных производных пиримидина в виде рацематов или оптических изомеров | |
| US6127362A (en) | 9,10-diazatricyclo[4,4,1,12,5 ] decane and 2,7-diazatricyclo [4,4,0,03,8 ] decane derivatives having analgesic activity | |
| US4002638A (en) | Benzazepine derivatives | |
| CA1219264A (en) | Benzobisoxazinetetrones | |
| US3476755A (en) | 8,13-diazasteroids | |
| US4185104A (en) | Tranquillizing complexes | |
| US4584313A (en) | (Substituted-phenyl)-5-oxo-2-pyrrolidinepropanoic acids and esters thereof, and use for reversing electroconvulsive shock-induced amnesia | |
| US3202663A (en) | Ring e substituted yohimbanes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RH | Patent void |